3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
6
Phase 3
2
Phase EARLY_PHASE1
1
Phase 4
1
Phase 1/2
1
Sponsor
Interventions
Specimen Handling
49
pembrolizumab
44
Magnetic Resonance Spectroscopy
37
Biopsy
35
Cyclophosphamide
33
fludarabine
28
Cetuximab
20
Cisplatin
19
Carboplatin
19
Bevacizumab
16
atezolizumab
15
Radiation
15
venetoclax
14
Fluorouracil
14
fludarabine phosphate
13
Radiotherapy
13
Leucovorin
13
Nivolumab
12
Gemcitabine
12
Pemetrexed
11
Oxaliplatin
11
Cytarabine
11
Irinotecan
10
130-nm albumin-bound paclitaxel
10
Prednisone
9
Paclitaxel
9
Immunoglobulin G
9
Fulvestrant
9
durvalumab
8
Temozolomide
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Phase 1
×
pirtobrutinib
×
30 days
×
Clear all
No trials found.